The criteria are being widened to include more doctors in addition to the 15,000 already invited.

Short summaries of clinically-relevant COVID-19 stories from the week ending 3 April.

A National Patient Safety Alert has been issued on the risk for harm from brief interruption of HFNO during in-hospital patient transfer.

Italian phase 3 RCT shows most outcomes were numerically but not statistically superior.

Hospitals are issuing directives to cancel or postpone "elective" surgery.

Mindfulness apps decrease anxiety and burnout in physicians

Less than one in five patients in England with stage III NSCLC receive optimal multimodality treatment.

MAGEC Systems should not be used in the UK until further notice.

More than a dozen new but incremental recommendations have been added.

Analysis of a UK PCC patient registry finds treatment is often started in the late disease stage.

Two potential vaccines against COVID-19 have entered phase I clinical trials.

Hervé Maisonneuve, Public health physician reminds us of the basic principles of drug development and the dangers that stems from the confiscation of scientific speech by non-scientific journalists and politicians.

Hundreds of clinical trials are currently being investigated in the fight against SARS-CoV-2. The world is working together at an unprecedented rate to find an effective therapy – a summary of the highlights.

Another benefit of breast cancer treatment based on evaluation of nearly 58,000 women.